AI-generated summary
In a study of 46 rats with critical-sized skull defects, the authors compared leukocyte and platelet-rich fibrin (LPRF) with and without 810 nm photobiomodulation, using bone graft material and saline as controls. The authors report that the combined treatment was associated with significantly more new bone (16.61%) than the control group (6.84%) after 30 days. They note that this benefit needs confirmation with larger samples and longer follow-up.
- Participants
- 46
- Who or what was studied
- Forty-six male Wistar rats with 8 mm critical-sized calvarial defects, randomly assigned to four groups
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The abstract states that the benefit needs confirmation with larger sample sizes and longer follow-ups, and the study was conducted in rats after 30 days.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
- Power
- 200 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Control group, Fluence, Collagen, Laser, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.